|
|
Attention Providers and Stakeholders of NDPP Program Services: Draft Rate Model Public Review and Comment |
General Notifications for All Providers |
|
|
Application Fee for 2023 Reminder, CR 114074 |
General Notifications for All Providers |
|
|
UPDATE: Pfizer and Moderna COVID-19 Bivalent Vaccine Authorized for Use in Individuals Aged Six Months to Five Years |
General Notifications for All Providers |
|
|
Electronic Visit Verification (EVV) Trainings and Forums |
Long Term Care Services |
|
|
Medicare Standardization Adjustments |
General Notifications for All Providers |
|
|
Section 50, Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF-IID) Rate Update, CR 113786 |
General, All Services |
|
|
Section 103, Rural Health Clinic (RHC) Rate Update, CR 114016 |
Hospital & Clinic Services |
|
|
Ambulatory Payment Classifications (APC) Claims Overpaying, CR 114133 |
Hospital & Clinic Services |
|
|
Section 31, Federally Qualified Health Center (FQHC) Rate Updates, CR 114022 |
Hospital & Clinic Services |
|
|
Reminder for Billing Attending Provider on UB-04 and 837I Claims, CR 110840 |
General, All Services |
|
|
Donor Breast Milk Coverage for Infants Under 12 Months, CR 113541 |
Hospital & Clinic Services |
|
|
Emergency Use Authorization (EUA) Revoked for Bebtelovimab 175 mg, CR 114106 |
General Notifications for All Providers |
|
|
Application Fee for 2022 Reminder, CR 114074 |
General Notifications for All Providers |
|
|
Electronic Visit Verification (EVV) Trainings and Forums |
Long Term Care Services |
|
|
Correction: Application Fee for 2023 Reminder, CR 114074 |
General Notifications for All Providers |
|
|
Attention Section 67, Nursing Facility Maine Veterans Home Providers - Supplemental Payment Information |
Long Term Care Services |
|
|
Attention Section 97, Appendix D Children’s Residential Care Facility Providers - Supplemental Payment Information |
Behavioral Health (BH) |
|
|
Pfizer and Moderna COVID-19 Bivalent Vaccine Authorized for use in individuals aged Six Months to Five Years |
General Notifications for All Providers |
|
|
Rate Determination Initiation Notice: National Diabetes Prevention Program |
General Notifications for All Providers |
|
|
(Corrected Effective Date) Pfizer and Moderna COVID-19 Bivalent Vaccine Authorized for use in individuals aged Six Months to Five Years |
General Notifications for All Providers |